Pradaxa, Xarelto and Eliquis are drugs that fall under a new class of medications known as “new oral anticoagulants” or NOACs. Patients who suffer from atrial fibrillation require an anticoagulant to reduce the risk of strokes and serious blood clot disorders that can be fatal. For many years, Warfarin has…
Updated: